Why VCs fell in love with pharma R&D in 2021
pharmaphorum
APRIL 5, 2022
That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity. And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might.
52 
Let's personalize your content